Site Search

Displaying results 621 - 630 of 893

Patient centricity: what is it and how to make it meaningful? | Roundtable discussion at DIA EuroMeeting

Event | 29/03/2017 | Glasgow, UK

IMI teamed up with the DIA (Drug Information Association) to organise a roundtable discussion entitled 'Patient centricity: What is it and how can we make it meaningful?' on 29 March 2017 during the 29th DIA Annual Euromeeting in Glasgow, UK. Patient centricity has never been so ...

'It was a really fantastic experience' – an interview with the MARCAR project coordinator

News | 13/01/2017 |

Success stories from projects

Cancer risk assessment is one of the most important steps during the development of new medicines. Launched in 2010, IMI’s MARCAR project aimed to develop early biological clues – biomarkers – which could help predict which drugs might lead to tumour growth. At the end of the ...

TransQST

Project| Closed | IMI2 |
Tools for predicting/monitoring efficacy

Translational quantitative systems toxicology to improve the understanding of the safety of medicines

HARMONY

Project| Ongoing | IMI2 |
Cancer
BD4BO
Big data and knowledge management
Real-world data, evidence

Healthcare alliance for resourceful medicines offensive against neoplasms in hematology

RESCEU

Project| Ongoing | IMI2 |
Respiratory diseases
Infectious diseases
Biobanks
Regulatory and HTA processes

Respiratory syncytial virus consortium in Europe

ROADMAP

Project| Closed | IMI2 |
Neurodegenerative diseases
Alzheimer's disease
BD4BO
Big data and knowledge management
Real-world data, evidence

Real world outcomes across the AD spectrum for better care: multi-modal data access platform

BEAT-DKD

Project| Ongoing | IMI2 |
Diabetes & metabolic disorders

Biomarker enterprise to attack DKD

PHAGO

Project| Ongoing | IMI2 |
Neurodegenerative diseases
Alzheimer's disease
Stem cells
Target identification
Drug discovery

Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33

MOPEAD

Project| Closed | IMI2 |
Neurodegenerative diseases
Alzheimer's disease
Patient involvement in R&D

Models of patient engagement for Alzheimer’s disease

'We took the lead over US-based projects' – an interview with SUMMIT project coordinators

News | 12/01/2017 |

Success stories from projects

Before SUMMIT started in 2009, ongoing research on diabetic complications in Europe was scattered amongst various countries. Fast forward six years, and Europe – by joining forces and activities - has climbed to the top of the research ladder in this field, coming close to or ...